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Abstract
Background: In the field of regenerative medicine, delivery of human adipose-derived mesenchymal stem/stromal
cells (hASCs) has shown great promise to promote wound healing. However, a hostile environment of the injured
tissue has shown considerably to limit the survival rate of the transplanted cells, and thus, to improve the cell
survival and retention towards successful cell transplantation, an optimal cell scaffold is required. The objective of
this study was to evaluate the potential use of wood-derived nanofibrillar cellulose (NFC) wound dressing as a cell
scaffold material for hASCs in order to develop a cell transplantation method free from animal-derived components
for wound treatment.
Methods: Patient-derived hASCs were cultured on NFC wound dressing without cell adhesion coatings. Cell
characteristics, including cell viability, morphology, cytoskeletal structure, proliferation potency, and mesenchymal
cell and differentiation marker expression, were analyzed using cell viability assays, electron microscopy,
immunocytochemistry, and quantitative or reverse transcriptase PCR. Student’s t test and one-way ANOVA followed
by a Tukey honestly significant difference post hoc test were used to determine statistical significance.
Results: hASCs were able to adhere to NFC dressing and maintained high cell survival without cell adhesion coatings
with a cell density-dependent manner for the studied period of 2 weeks. In addition, NFC dressing did not induce any
remarkable cytotoxicity towards hASCs or alter the morphology, proliferation potency, filamentous actin structure, the
expression of mesenchymal vimentin and extracellular matrix (ECM) proteins collagen I and fibronectin, or the
undifferentiated state of hASCs.
Conclusions: As a result, NFC wound dressing offers a functional cell culture platform for hASCs to be used further for
in vivo wound healing studies in the future.
Keywords: Nanofibrillar cellulose, Adipose-derived mesenchymal stem/stromal cell, Cell transplantation, Cell scaffold,
Regenerative medicine, Wound healing
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Background
Wounds, which fail to heal in a timely manner for
instance due to infection, tissue hypoxia, necrosis, or ele-
vated levels of inflammatory cytokines, are classified as
chronic wounds that are a heavy burden to healthcare
systems, and which decrease the quality of life of the
patients [1, 2]. Currently, treatment methods for chronic
wounds are inefficient, and there is a high need for more
advanced wound treatment therapies.
Mesenchymal stem/stromal cells (MSCs), such as hu-
man adipose-derived mesenchymal stem/stromal cells
(hASCs), are multipotent and self-renewable progenitor
cells that can be isolated from multiple sources and have
been widely studied for the tissue engineering applications
[3, 4]. However, the population of MSCs is heterogenous,
and they lack a specific cell surface marker [5]. Thus,
MSCs are characterized according to three criteria from
the International Society for Cellular Therapy: (1) their
ability to adhere to plastic; (2) differentiate to adipocytes,
osteoblasts, and chondrocytes under standard in vitro
conditions; and (3) their expression of specific surface
markers CD73, CD90, and CD105. MSCs must also
express only low levels of major histocompatibility
complex (MHC) class II molecules [5–9].
Human ASCs are isolated from a stromal vascular frac-
tion (SVF) obtained from a lipoaspirate [10]. These cells
have shown to have immunomodulatory properties via
paracrine signaling and extracellular vesicles [11, 12]. Due
to these properties, hASCs have been tested in multiple
preclinical and clinical settings for instance for the treat-
ment of autoimmune disease and graft-versus-host disease
[13–15]. The immunomodulatory properties make them
also suitable for allogenic and even xenogeneic transplant-
ation. In addition, hASCs are especially suitable for wound
healing applications due to their ability to secrete a wide
variety of paracrine factors related to wound healing and
due to their differentiation capability [16, 17]. In vivo, they
have been shown to stimulate angiogenesis and to
enhance wound closure [18, 19]. However, obstacles exist
for successful cell transplantation including poor survival
and low retention of cells in a target tissue, which typically
is caused by the accumulation of cells in other tissues or
enzymatic digestion of the single-cell suspension after
systemic or topical administration [20, 21].
To overcome these issues, more emphasis has nowadays
put on the development of biomaterial cell scaffold that
would support cell survival and function. Nanofibrillar
cellulose (NFC) is a wood-derived biomaterial of which
properties make it an attractive option as a cell scaffold
for biomedical applications. NFC commonly manufac-
tured from wood pulp is non-toxic, biocompatible in
humans, and biodegradable in nature [22]. NFC forms
viscose hydrogels even with low fibril concentrations due
to the naturally high affinity of cellulose to water and
strong interactions between cellulose fibers. The dimen-
sions of NFC fibers resemble the dimensions of natural
collagen, and thus, the viscoelastic properties and diffusion
of proteins from NFC resemble the properties of extracel-
lular matrix, which make NFC hydrogel applicable for 3D
cell culturing [23]. NFC hydrogel has been shown to
improve the formation of 3D tumor spheroids and to
support the pluripotency of stem cells spheroids [23–26].
In addition to 3D cell culturing, NFC hydrogels can be
utilized in the controlled release of drugs [27, 28]. Further-
more, NFC hydrogel can be modified into different forms,
such as films and dressings [29, 30].
We have previously shown in a clinical study that
NFC-based wound dressing supports the healing of skin
graft donor sites [29, 31]. In the present study, we evalu-
ated the potential of NFC dressing as the cell scaffold
material for hASCs to be used as a cell transplantation
method in the future. Our hypothesis was that NFC
dressing offers a culture platform for hASCs and
supports their survival and characteristics.
Methods
Materials
Human ASCs were isolated from adipose tissue samples
acquired from surgical procedures at the Department of
Plastic Surgery, Tampere University Hospital, with
written informed consent. The study was carried out in
accordance with the Ethics Committee of Pirkanmaa
Hospital District, Tampere, Finland (R15161). Three
different NFC wound dressings, type 1 and 3 NFC dress-
ings and type 4 NFC dressing (FibDex®), were kindly
supplied by UPM-Kymmene Corporation (UPM),
Finland. All dressings were manufactured from unmodi-
fied wood-based NFC as described previously by
Hakkarainen et al. [29] and Koivuniemi et al. [31].
Cell isolation and characterization
Cell isolation and characterization were performed as de-
scribed previously by Kyllönen et al. [32]. The hASCs were
obtained from subcutaneous adipose tissue of 12 donors
(11 females, 1 male; mean age 56.7 ± 7.9) using Dulbecco’s
modified Eagle’s medium/Ham’s Nutrient Mixture F-12
(DMEM/F12; Thermo Fisher Scientific, USA), 5% (v/v)
human serum (HS; PAA Laboratories, Austria), 1% (v/v)
penicillin/streptomycin (PS; Invitrogen, USA), and 1% (v/
v) L-alanyl-L-glutamine (GlutaMAX, Invitrogen). After the
isolation process, cells were characterized at passage 1 by
their differentiation capability towards adipocyte and
osteogenic lineages using Oil red and Alizarin red S stain-
ings (Sigma-Aldrich, USA), respectively, as well as by cell
surface marker expressions using flow cytometry as
described previously by Vuornos et al. [33]. The results
indicated a mesenchymal origin of the isolated hASCs (see
Additional file 2).
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Cell culture
Cells were utilized between passages 3 and 6, and all
experiments were repeated with cells isolated from indi-
vidual donors (n numbers refer to the number of donors,
which is the number of repeats of separate experiments).
Used cell densities varied between 10,000 cells/cm2
(10k) and 500k. Cells were cultured in MEM-α Supple-
ment medium (MEM-α; Gibco, UK) with 6% of human
serum (v/v) (HS; Sigma-Aldrich) at + 37 °C and 5% CO2.
Cell culture and adherence with NFC dressing
Cells were cultured on the patterned side of three different
NFC dressings without cell adhesion coatings. For cell
viability, adherence, and PCR assays, cells were cultured
with NFC dressings on low-adhesion 96-well inertGrade
BRANDplates® (Sigma-Aldrich) and cells cultured on
normal tissue culture plastic well plates (SARSTEDT,
Germany) served as a control. For scanning electron
microscopy (SEM), transmission electron microscopy
(TEM), and immunocytochemistry (ICC), cells were
cultured on eight-chamber slides (Chamber Slide™ system
8-well Permanox slide plates, Nunc™ Lab-Tek™; Thermo
Fisher Scientific) and cells cultured on cover glasses served
as controls. Cell adherence for type 3 NFC dressing was
evaluated calculating the number of non-adhered cells
from the collected culture medium at several time points
using a Bürker chamber.
Cell viability
Cell viability was evaluated by mitochondrial activity and
released lactate dehydrogenase (LDH) on three different
NFC dressings. Mitochondrial activity was evaluated with
alamarBlue™ Cell Viability Reagent (Invitrogen) by adding
100 μl of alamarBlue™ solution diluted with culture media
to a final volume of 10% (v/v) to the cells and incubating
for 3 or 4 h at + 37 °C. After the incubation, 80 μl of the so-
lution was transferred to a black 96-well plate (Nunc®
MicroWell 96 optical bottom plates; Sigma-Aldrich), and
fluorescence was measured using Varioskan LUX (Thermo
Scientific, USA) and SkanIt RE- program 5.0 (excitation
560 nm, emission 590 nm). The fluorescence signal was
normalized to the signal from control cells and blank
control samples without cells.
Released LDH was evaluated with Pierce™ LDH Cyto-
toxicity assay kit (Thermo Scientific). The released LDH
was measured using the chemical compound-mediated
cytotoxicity assay according to the manufacturer’s
instructions. To prepare the spontaneous LDH activity
controls, 2-h incubation of sterile ultrapure water added
to cells was used for day 1 measurement, while
overnight incubation was used for day 3 and day 5 mea-
surements. Absorbances were measured at 490 nm and
680 nm using Varioskan LUX and SkanIt RE program
5.0, respectively. Cytotoxicity results were calculated
according to the manufacturer’s instructions by normal-
izing the signal from samples to the signal from spon-
taneous LDH activity controls and maximum LDH
release controls.
Electron microscopy
For scanning electron microscopy (SEM), cells were
seeded on type 3 NFC dressing and fixed on day 7 with
2% glutaraldehyde (Sigma-Aldrich) in PBS for 2 h at
room temperature (RT). Samples were coated with
platinum, and the imaging was performed with FEI
Quanta 250 Field Emission Gun SEM using 4.0–5.0 kV
and 2.0–4.0 spot in high vacuum.
For transmission electron microscopy (TEM), cells
were seeded on type 3 NFC dressing and fixed on day 7
with 2% glutaraldehyde in 0.1 M sodium phosphate
buffer pH 7.4 for 2 h at RT. Imaging was performed
with Jeol JEM 1400 Tungsten Electron gun TEM using
80.0 kV.
Immunocytochemistry
Cells were seeded on type 3 NFC dressing and fixed with
4% paraformaldehyde (PFA) for 20 min on day 1 or 7.
After that, cells were washed three times with 0.1% (v/v)
Tween 20 detergent (Sigma-Aldrich) in 1× Dulbecco’s
phosphate-buffered saline without calcium and magne-
sium (DPBS; Gibco). Blocking and permeabilization were
performed using 0.1% (v/v) Triton X-100 in PBS
containing 3% (m/v) bovine serum albumin (BSA;
Sigma-Aldrich) and 0.3M glycine (99%; Sigma-Aldrich)
for 1 h at RT. Anti-mouse vimentin (1:50; Santa Cruz
Biotechnology, USA), anti-rabbit Ki67 (1:200; Abcam,
UK), anti-rabbit collagen α-1 (0,5 μg/ml; BosterBio,
USA), anti-mouse fibronectin (10 μg/ml; R&D Systems,
USA), and conjugated Phalloidin Alexa 488 (1:40;
Thermo Fisher Scientific) antibodies in 0.1% (v/v) Tween
20 in DPBS containing 3% (m/v) BSA) were added to the
cells and incubated overnight at + 4 °C. On the following
day, cells incubated with an unconjugated antibody were
washed three times with washing buffer (0.1% (v/v)
Tween 20 in DPBS) before adding Alexa Fluor 488 goat
anti-mouse IgG (1:500; Life Technologies, USA) or
Alexa Fluor 594 donkey anti-rabbit IgG (1:500; Life
Technologies) in 0.1% (v/v) Tween 20 in DPBS contain-
ing 5% (m/v) BSA. Subsequently, all the cells were
washed three times with washing buffer and once with
0.1M Tris buffer pH 7.4. Cells were mounted with
ProLong Diamond Antifade Mountant with DAPI (Life
Technologies) and covered with cover glass (Menzel-
Gläser, Germany). Samples were imaged with Aurox
Clarity Laser Free Confocal HS wide-field microscopy
and analyzed with ImageJ 2.0 software.
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Quantitative PCR
Samples were prepared as described for cell viability as-
says. After 1-week culturing, cells were detached and
washed twice with ice-cold DPBS before extracting total
RNA using the RNeasy® Mini kit (Qiagen, Germany) ac-
cording to the manufacturer’s instructions. cDNA was
prepared from total RNA using High-Capacity RNA-to-
cDNA Kit (Thermo Fisher Scientific). Quantitative PCR
(qPCR) reactions were performed using Fast SYBR®
Green Master Mix (Applied Biosystems, USA) in a total
volume of 20 μl, using 2 μl of cDNA as a template. As-
says were run in triplicate including a non-template
control (water) and a non-amplification control (no
SYBR® Green) and using StepOnePlus detection system
with StepOne Software v2.3. The following conditions
were used: an initial activation and denaturation step of
95 °C for 30 s and 40 amplification cycles consisting of
95 °C for 5 s, 60 °C for 15 s, 72 °C for 10 s, and 72 °C for
1 min. Gene expression levels were analyzed using the
relative standard curve method, with twofold serial
dilutions of a control sample prepared for the standard
curve. β-2-Microglobulin (β-2-m) was used as an
endogenous control gene. The used primer sequences
are given in Table 1.
Reverse transcriptase PCR
Total RNA from cells was prepared and used for cDNA
synthesis as described above. Reverse transcriptase (RT)
PCR for CD45 was performed using Taq DNA polymer-
ase (Invitrogen) and the following conditions: 95 °C for
3 min, 95 °C for 30 s, 62 °C for 30 s, 72 °C for 1 min, and
72 °C for 5 min, for 35 cycles, and including a non-tem-
plate control (NTC; water). The primer sequences for
CD45 are given in Table 1.
Statistical analysis
Significant differences between the two groups were ana-
lyzed using Student’s t test and differences between
three and more groups using one-way ANOVA followed
by a Tukey HSD post hoc test. Values of p < 0.05 were
considered statistically significant.
Results
Type 3 NFC dressing offers a culture platform for hASCs
To evaluate the effect of NFC on the cell viability of
hASCs, the cells were cultured on NFC dressings (Fig. 1a)
for 7 days. During the culturing with 30k–125k cell
densities, hASCs showed low cell viabilities with each
dressing type (see Additional file 3 A-C). When the dif-
ferent NFC dressings were compared with each other,
type 3 NFC dressing showed the highest and type 1 NFC
dressing the lowest cell viabilities, while any of the NFC
dressings did not induce remarkable cell cytotoxicity
with 50k–150k cell densities (see Additional file 3 D-F).
Based on these results, type 3 and type 4 NFC dressings
were chosen for further studies.
Scanning electron microscopy (SEM) was used to evalu-
ate the effects of NFC dressings to the morphology of
cells. Interestingly, by using cell densities of 300k and
500k, hASCs cultured on type 3 NFC dressing showed
similar cell morphology and adhered monolayer through-
out the dressing compared with the control cells cultured
on a glass after 7 days of culturing (Fig. 1b). In contrast,
with 150k and 200k cell densities, the cells appeared as
small spherical cells growing distant from each other (see
Additional file 4). Only very few cells were observed grow-
ing on type 4 NFC dressing, and thus, this dressing type
was excluded from further studies.
Table 1 Primer sequences used in quantitative and reverse
transcriptase PCR assays
Gene primer sequence 5′-3′
CD73 F: CTTAACGTGGGAGTGGAACC
R: TCTAGCTGCCATTTGCACAC
CD90 F: CGCTCTCCTGCTAACAGTCTT
R: CAGGCTGAACTCGTACTGGA
CD105 F: CTAACTGGCAGGGGAGACAG
R: CTCCATGTGGCAGGAGCTA
CD166 F: ATTGAAGTTTTATTTGGCAGGAA
R: GGCTTAGCCATGCAAAACA
CD34 F: TCTGGATCAAAGTAGGCAGGA
R: GATCCAGCCTCAGAGGAAGA
CD45 F: GCAAAGATGCCCAGTGTTCCACTT
R: ATCTGAGGTGTTCGCTGTGATGGT
CCND1 F: TATTGCGCTGCTACCGTTGA
R: CCAATAGCAGCAAACAATGTGAAA
OCT4 F: CAGTGCCCGAAACCCACAC
R: GGAGACCCAGCAGCCTCAAA
SOX2 F: CTCCGGGACATGATCAGC
R: GGTAGTGCTGGGACATGTGAA
NANOG F: GCAGAAGGCCTCAGCACCTA
R: GGTTCCCAGTCGGGTTCAC
PPARγ F: TCAGCGGGAAGGACTTTATGTATG
R: TCAGGTTTGGGCGGATGC
RUNX2 F: GTCTTACCCCTCCTACCTGA
R: TGCCTGGCTCTTCTTACTGA
COL2A1 F: CGTCCAGATGACCTTCCTACG
R: TGAGCAGGGCCTTCTTGAG
FGF2 F: ATGGCAGCCGGGAGCATCACCCACG
R: TCAGCTCTTCGCAGACATTGGAAG
TNF-α F: ATGAGCACTGAAAGCATGATCC
R: GAGGGCTGATTAGAGAGAGGTC
VEGF F: TGCTTCTGAGTTGCCCAGGA
R: TGGTTTCAATGGTGTGAGGACATAG
IL-6 F: AACCTGAACCTTCCAAAGATGG
R: TCTGGCTTGTTCCTCACTACT
β-2-m F: CTCGCGCTACTCTCTCTTTCTG
R: GCTTACATGTCTCGATCCCACT
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As shown in Fig. 1c, high cell viabilities were observed
over a 2-week culturing with 300k and 500k cell dens-
ities on type 3 NFC dressing. Only statistically significant
decrease (*p < 0.05) compared with control cells was de-
tected on day 1 with 500k cell density. The highest cell
viabilities were observed with 300k cell density that
showed no remarkable cytotoxicity on day 4 (12.47 ±
1.61%) or day 7 (4.35 ± 0.88%). More than 97% of seeded
cells (97.27 ± 2.49% for controls and 98.04 ± 1.50% for
cells cultured on type 3 NFC dressing) were adhered
within 24-h culturing (Fig. 1d). Compared with the con-
trol cells, cell adherence was statistically lower (*p <
0.05) only at a time point of 1 h. Taken together, 300k
cell density and type 3 NFC dressing appeared to offer
the most optimal culture conditions for hASCs without
cell adhesion coatings. These conditions were therefore
used for the following experiments.
hASCs adhere to type 3 NFC dressing
Transmission electron microscopy (TEM) was used to
study the interactions between hASCs and type 3 NFC
dressing further. At 7 days of culture, hASCs were
shown to grow on type 3 NFC dressing with layered dis-
tribution, meaning that the cells grew partly on top of
each other, which was also observed by SEM imaging.
Interaction of hASCs with type 3 NFC dressing was
confirmed to occur only on the patterned side of the
dressing, the cells being adhered in the close vicinity of
the patterns (Fig. 2a). A closer observation revealed
interactions of cells with type 3 NFC dressing by focal
adhesions (Fig. 2b, c). Therefore, it can be stated that
hASCs were able to adhere to the type 3 NFC dressing.
The cytoskeletal structure and function of hASCs is
maintained on type 3 NFC dressing
In order to study further, whether type 3 NFC dressing
alters the properties of hASCs, their cytoskeletal struc-
ture and proliferation potency were addressed by
immunocytochemical staining in order to visualize the
filamentous actin (F-actin), mesenchymal vimentin, and
proliferating cells by using antibody against Ki67.
Vimentin staining revealed both polygonal and elongated
cell morphologies both in control cells and in cells
grown on type 3 NFC dressing, and proliferating cells
Fig. 1 Culturing of hASCs on type 3 NFC dressing without cell adhesion coatings. SEM micrographs from a NFC dressings and b from hASCs cultured
for 7 days with cell densities of 300,000 cells/cm2 (300k) and 500k (n = 2). Similar morphology compared with the control cells were observed with
both cell densities. Scale bars, 200 μm. Magnification, × 500. c Cell viability of hASCs with cell densities of 300k and 500k. High cell viabilities were
observed especially with 300k cell density during 2-week culturing compared with the control cells cultured on plastic (all values are mean ± SEM, n =
3). d Majority of seeded cells adhered to the surface of type 3 NFC dressing within 24-h culturing. Compared with control cells, a lower number of
adhered cells were observed only at 1-h time point (all values are mean ± SEM, n = 3, at 24 h time point n = 2). *p < 0.05. NFC, nanofibrillar cellulose
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were present in both samples (Fig. 3a). However, the
quantitated overall proliferation rate of hASCs on days 1
and 7 was remarkably low both in the control cells and
in cells grown on type 3 NFC dressing. On day 7, phal-
loidin staining revealed an invariable structure of F-actin
compared with the control cells (Fig. 3b).
The observation that hASCs maintained adherent
during the culturing on type 3 NFC dressing suggested
that they are capable of secreting their own extracellular
matrix (ECM). The ECM formation was visualized by
collagen I and fibronectin expression. As shown in Fig. 4,
no difference in the expression of these ECM proteins
was observed in hASCs after 1-week culturing on type 3
NFC dressing compared with the control cells. In
addition, no difference in the organization of fibronectin
was observed (Fig. 4b). Taken together, hASCs main-
tained their cytoskeletal structure, proliferative nature,
and expression of ECM proteins on type 3 NFC
dressing.
hASCs maintain an undifferentiated state when cultured
on type 3 NFC dressing
Expression of hASC-specific cell surface antigens, cell
cycle and stemness markers, and differentiation markers
was analyzed using qPCR. When culturing the cells with
300k cell density with or without type 3 NFC dressing,
no statistically significant changes in the expression were
observed for cell surface antigens CD73, CD90, CD105,
CD166, or CD34 (Fig. 5a) compared with the control
cells of 30k cell density, which was considered as an
optimal cell density for hASCs grown on tissue culture
plastic. In addition, no statistically significant differences
were observed in the expression of a positive cell cycle
regulator CCND1; stemness markers OCT4, SOX2, and
NANOG; an adipogenic marker gene PPARγ; an osteo-
genic marker RUNX2; or a chondrogenic marker COL2A1
(Fig. 5a). In contrast to the positive expression of markers
detected by qPCR, the expression of a specific cell surface
antigen CD45 analyzed by RT-PCR was absent in hASCs
regardless of the culture condition (Fig. 5b).
Enzyme-linked immunosorbent assay (ELISA) was
used to measure the amount of growth factors and cyto-
kines secreted by hASCs cultured on type 3 NFC dress-
ing. In the preliminary data measured from samples of a
suboptimal low cell density, no secretion of various cyto-
kines, including interleukin (IL)-4, IL-5, IL-10, and IL-
12p70; interferon (IFN)-γ; epidermal growth factor
(EGF); vascular endothelial growth factor (VEGF); trans-
forming growth factor (TGF)β-1; and granulocyte col-
ony-stimulating factor (G-CSF), was detected with
conditions applied in this study (Additional file 1). How-
ever, a statistically significant increase was detected in
fibroblast growth factor (FGF)-2 (p = 0.0032), IL-6 (p =
0.025), and tumor necrosis factor (TNF)-α (p = 0.012) se-
cretion levels (see Additional file 5). After discovering
the optimal culture conditions for hASCs on type 3 NFC
dressing, the expression of these cytokines were further
analyzed using qPCR assay. In contrast to the prelimin-
ary ELISA results, no statistically significant increase was
observed in FGF2, TNF-α, or IL-6 expression levels with
a higher cell density that showed equal expression levels
compared with control cells (Fig. 6). Further, the expres-
sion of VEGF was quantitated as an additional growth
factor, given its importance in wound healing process.
No significant difference was detected in the expression
of VEGF in hASCs cultured on NFC dressing compared
with control cells. Consequently, type 3 NFC dressing
did not alter the cytokine expression or undifferentiated
state of hASCs.
Fig. 2 Transmission electron microscopy micrographs from hASCs
cultured on type 3 NFC dressing for 7 days. a Cells adhere in the vicinity
of patterns (asterisk) in the dressing surface (n= 2). b, c Focal adhesions
(arrows) between a cell and NFC dressing. NFC, nanofibrillar cellulose
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Discussion
We have previously shown in a clinical study that NFC
wound dressing performs comparably with a commercial
wound dressing for the treatment of skin graft donor
sites [31]. In the current project, we studied the potential
use of NFC dressing as a cell-culturing platform for
multipotent hASCs in order to develop cell transplant-
ation method free from animal-derived components for
wound care. To that end, we analyzed hASCs cultured
with various cell densities on three different NFC wound
dressings previously studied in patients.
hASCs are well established to promote wound healing
[34]. However, the survival rate of the transplanted cells
has shown to be diminished by the inflammatory
response at a transplantation site [35, 36]. Therefore, a
special consideration should be made to improve cell
survival and retention towards successful cell therapy in
the future, for instance, by using biomaterials as a cell
scaffold. In previous studies, hASCs cultured with bio-
materials have shown to promote wound healing in vivo
[37–39]. However, different animal-derived components
used in the scaffold and cell culture media or as cell
adhesion coatings limit the translation of new tissue
engineering innovations to clinical applications [40]. The
potential of NFC dressing for a cell transplantation
method to be applied in wound care is increased consid-
erably due to the exclusion of all the animal-derived
materials from the biomaterial. Consequently, our study
is in good agreement with the recommendations of the
Food and Drug Administration (FDA) [41].
Differing properties of biomaterials, caused by differ-
ent manufacturing processes, are well known to alter the
function of cells [42–45]. In this study, three different
NFC dressings varying in topography and amount of
NFC were studied with multiple cell densities in order
to identify the optimal culture conditions for hASCs. As
a result, type 3 NFC dressing was observed to offer func-
tional cell culture conditions with 300k cell density and
without cell adhesion coatings according to the cell
viability assays and SEM. Type 3 NFC dressing did not
induce any remarkable cytotoxicity [46], and hASCs
adhered to the surface of type 3 NFC dressing within 24
h and showed similar morphology compared with the
control cells after 1-week culturing. However, the used
cell density was excessively higher compared with the
traditionally used cell densities that have been identified
to affect the growth and functionality of cells [47–49]. In
specific, high cell density has been shown to promote
paracrine action of hASCs [49], which might benefit the
wound repair process. Nevertheless, hASCs maintained
high cell viability during the 2-week culturing. However,
cell viability was cell density-dependent, and an optimal
culture of hASCs on type 3 NFC dressing required high
cell density, which might limit the use of the dressing in
some cell culture applications.
One of the most important functions of biomaterials for
cell transplantation is their ability to support cell adhesion,
which is mainly an outcome from the physiochemical
properties of the surface of the material. In addition, these
properties have been shown to control cell behavior [50].
We observed that hASCs seeded with 300k cell density on
type 3 NFC dressing express similar flattened morphology
compared with the control cells, which typically indicate
relatively strong attachment to the surface [51, 52]. Similar
results were not observed with lower cell densities or with
other NFC dressing types, which highlights the import-
ance of optimal cell density and material properties for
cell attachment and growth [53].
Fig. 3 hASCs cultured on type 3 NFC dressing for 7 days. a Cells expressing the mesenchymal vimentin (vimentin; green) and showing proliferation
capacity (Ki67; red). b F-actin structure (phalloidin; green). DAPI, blue. N = 2. Scale bars, 50 μm. Magnification, × 63. NFC, nanofibrillar cellulose
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Focal adhesions have been found to facilitate interac-
tions between MSCs and a biomaterial [54]. Our results
showed that hASCs mainly interact with type 3 NFC
dressing on patterned sites through focal adhesions indi-
cating a mechanical interaction between hASCs and the
biomaterial. Focal adhesions are large protein complexes
and a special form of cell linkage with ECM involving
the cell cytoskeleton that provides necessary interac-
tions, e.g., cell migration [55]. The result is in good
agreement with the fact that hASCs maintained high cell
viability and adherence during the culture and suggests
that the contact with the biomaterial was functional. In a
more detailed analysis of cell morphology, visualization
of F-actin structure and mesenchymal vimentin expres-
sion revealed similar morphology and F-actin fiber align-
ment typical for fibroblast-like cells in hASCs grown on
type 3 NFC dressing compared with control cells.
MSCs are well known for their capability to form their
own ECM and thus provide stability [56, 57]. In our
study, hASCs were shown to express ECM proteins
collagen I and fibronectin after 1-week culturing, though
collagen I only showed intracellular location. This find-
ing suggests that hASCs are able to form ECM on type 3
NFC dressing. It is possible that the ECM production
would be even more prominent during longer culturing
periods.
To further characterize hASCs on type 3 NFC dress-
ing, we addressed their expression of various marker
genes. Similar expression levels were observed regarding
specific cell surface antigens, and stemness and differen-
tiation markers between hASCs cultured with or without
type 3 NFC dressing. These results are in good agree-
ment with the study of Mertaniemi et al. where they
demonstrated that hASCs cultured on glutaraldehyde
Fig. 4 Type 3 NFC dressing did not alter the expression of ECM proteins of hASCs. Immunocytochemistry for hASCs cultured on type 3 NFC
dressing for 7 days. Cells showing invariable formation of a collagen I (red) and b fibronectin (green) compared with the controls (n = 3). DAPI,
blue. × 20 magnification, scale bar 100 μm; × 63 magnification, scale bar 50 μm. NFC, nanofibrillar cellulose
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cross-linked nanocellulose threads coated with laminin
or CELLstart™ maintained their expression of mesenchy-
mal cell surface markers CD29, CD44, CD73, CD90, and
CD166 as well as lacked expression of CD45 and genes
involved in adipocyte maturation during 10-day cultur-
ing [58]. Taken together, it can be hypothesized that
with the right cell density and physiochemical proper-
ties, NFC dressing supports the cell attachment, func-
tion, and undifferentiated state of hASCs.
Notwithstanding that high cell density has shown to
affect the growth of the cells [59], hASCs maintained their
potency to proliferate at some level as analyzed by Ki67
and CCND1 expression. hASCs reveal high donor-to-
donor variance [60], which has shown to alter their
expression profiles [61] and, in some cases, even the func-
tion of cells. For instance, CD34, which is a stem cell
marker traditionally used to distinguish hASCs from other
cell types in SVF during the isolation process [62, 63], has
shown to alter the function of hASCs [64]. In a study
made by Suga et al., CD34+ hASCs exhibit shorter doub-
ling time compared with the CD34− hASCs, which in
contrast showed greater ability to differentiate towards
Fig. 5 Type 3 NFC dressing did not alter the undifferentiated state of hASCs. a Quantitative PCR for hASCs cultured on type 3 NFC dressing for 7 days.
Relative expressions normalized to the expression of endogenous control gene β-2-m for hASCs cultured with 300,000 cells/cm2 (300k) cell density
with (NFC 300k) or without (300k) type 3 NFC dressing for 7 days showing no statistical difference in the expression of specific cell surface antigens
CD73, CD90, CD105, CD166, or CD34; cell cycle marker CCND1; stemness markers OCT4, SOX2, and NANOG; or differentiation markers PPARγ, RUNX2, or
COL2A1 compared with 30k cell density. Ctrl 30k and 300k n = 4, NFC 300k n = 3. b Reverse transcriptase PCR. Negative expression of a specific cell
surface antigen CD45 was observed for hASCs regardless of the culture conditions. β-2-m, beta-2-microglobulin; NFC, nanofibrillar cellulose; NTC,
non-template control
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adipogenic and osteogenic cell lineages [64]. The authors
speculated that CD34 expression would correlate with the
capability to replicate as well as with differentiation
potential, stemness, and specific expression profiles of
angiogenesis-related genes. hASC population used in our
study showed positive expression of CD34, which might
correlate to the maintained proliferation competence and
undifferentiated state of hASCs. However, it is important
to notice that the expression profile of hASCs can be al-
tered also by culture conditions, methods, and time [63].
Moreover, Ahn et al. have shown that a rough surface top-
ography and hydrophilicity of the biomaterial can promote
the proliferative competence of hASCs [51]. With that in
mind and due to the properties of type 3 NFC dressing,
including high affinity to water and patterned surface, type
3 NFC dressing may support the competence of hASCs to
proliferate [50].
Since hASCs have a natural capability to affect the
wound healing process and to modulate the immune
reaction by secreting a wide variety of cytokines and
growth factors, we evaluated their inflammatory re-
sponse by measuring pro-inflammatory cytokines IL-6
and TNF-α [65]. In addition, the angiogenic potential of
hASCs was evaluated by measuring their expression of
FGF2 and VEGF. In the preliminary results with lower
cell densities, we observed increased FGF2, IL-6, and
TNF-α secretion in cells grown on NFC dressing, which
may indicate a reaction towards a foreign material [65],
result from suboptimal cell density, or propose enhanced
angiogenic potential and/or wound healing properties of
hASCs on NFC [66]. On the other hand, the used gelatin
coating on NFC dressing during the preliminary experi-
ments may have influenced the results since gelatin has
been shown to affect cell behavior and pro-inflammatory
cytokine secretion [67]. Extremely low, if any, secretion
levels of these proteins were observed in control sam-
ples, which may result from the lacking stimulation of
cells by inflammatory factors [68]. In contrast, we dis-
covered unchanged gene expression levels of FGF2,
TNF-α, and IL-6 in hASCs cultured on type 3 NFC
dressing compared with control cells when using the
higher cell density. Sukho et al. have shown that cell
seeding density affects greatly to the cytokine and
growth factor secretion levels of hASCs [49]. Further,
Fig. 6 Growth factor and cytokine expression of hASCs analyzed by
quantitative PCR. Relative expressions for hASCs cultured with 300,000
cells/cm2 (300k) cell density with (NFC 300k) or without (300k) type 3
NFC dressing for 7 days. No statistically significant difference was
observed in the expression of wound healing-related FGF2, TNF-α, IL-6,
and VEGF compared with 30k cell density. Ctrl 30k and 300k n = 4, NFC
300k n = 3. FGF2, fibroblast growth factor 2; IL-6, interleukin-6; NFC,
nanofibrillar cellulose; TNF-α, tumor necrosis factor alpha; VEGF,
vascular endothelial growth factor
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similar results have been observed by Patrikoski et al.,
who showed that different culture conditions modulate
the immunological properties of hASCs [69]. Our results
suggest that type 3 NFC dressing does not modify the
bioactivity of hASCs with an optimal 300k cell density.
That would be an advantage for potential future use of
NFC dressing as a cell therapy method for wound care.
The used cell density of 300k applied in this work is in
good agreement with in vivo studies, which already have
indicated enhanced wound healing using MSCs. How-
ever, the used cell densities have varied widely between
2 × 105 and 2 × 106 cells/cm2 per wound [17, 39, 70–72].
Even with 4 × 104 cells/cm2 have shown to enhance
wound healing in a clinical study performed with three
patients [73]. However, a better understanding about the
effect of different cell densities to the wound healing
process is still lacking. In addition, the cell amount ob-
tained from liposuctions needs to be taken into consid-
eration when developing new clinical applications. For
instance, in a study by Tarallo et al., the yield of hASCs
from liposuction aspirate fluid was 8.3 × 105 cells/ml
[74]. From a safe liposuction volume [75], the amount of
cells would be sufficient for type 3 NFC dressing to be
used in autologous cell transplantation even into the large
wound areas. Therefore, it can be stated that the cell dens-
ity of 300k is suitable for future use regarding wound
treatment. However, further in vitro and in vivo studies
are a warrant to be performed in the future to yield more
knowledge of the effects of type 3 NFC dressing to hASCs
and their potential in wound healing.
Conclusions
In this study, NFC wound dressing of a natural origin
showed to offer a cell culture scaffold for hASCs without
any animal-derived culture components or cell adhesion
coatings. NFC dressing does not induce any remarkable
cytotoxicity or alter the morphology, cytoskeletal struc-
ture, function, or undifferentiated state of hASCs. Based
on these findings, NFC dressing offers a functional cell
culture platform for hASCs. However, further in vitro and
in vivo studies are required to understand better the effect
of type 3 NFC dressing to the biological activity of hASCs
and their effect on wound healing before translation to the
clinical application.
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